{
    "code": "52026567",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026567",
    "time": "2020-09-25 15:41:07",
    "許可證字號": "衛部藥輸字第026567號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/07\/13",
    "發證日期": "104\/07\/13",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202656702",
    "中文品名": "優麗舒保濕型點眼液",
    "英文品名": "Optive Fusion TM Lubricant Eye Drops",
    "適應症": "暫時緩解因眼睛乾澀所引起灼熱感與刺激感。",
    "劑型": "472點眼液劑",
    "包裝": "100毫升以下塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "17醫師藥師藥劑生指示藥品",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CARBOXYMETHYLCELLULOSE SODIUM (EQ TO SODIUM CARBOXYMETHYLCELLULOSE), GLYCERIN (eq to GLYCEROL)",
    "限制項目": "02輸　入",
    "申請商名稱": "620118K767  台灣愛力根藥品股份有限公司",
    "申請商地址": "台北市中正區羅斯福路2段102號9樓",
    "主製造廠": [
        {
            "製造廠名稱": "FIE0008000  ALLERGAN PHARMACEUTICALS IRELAND",
            "製造廠廠址": "CASTLEBAR ROAD, WESTPORT,  CO. MAYO, IRELAND",
            "製造廠公司地址": "",
            "製造廠國別": "IRELAND",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9600006310",
            "成分名稱": "CARBOXYMETHYLCELLULOSE SODIUM (EQ TO SODIUM CARBOXYMETHYLCELLULOSE)",
            "含量描述": "",
            "含量": "5.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "9600013500",
            "成分名稱": "GLYCERIN (eq to GLYCEROL)",
            "含量描述": "",
            "含量": "9.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "010265670001-107-09-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026567&Seq=003&Type=9"
        },
        {
            "title": "010265670007-107-09-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026567&Seq=019&Type=8"
        },
        {
            "title": "010265670006-107-09-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026567&Seq=018&Type=8"
        },
        {
            "title": "010265670005-107-09-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026567&Seq=017&Type=8"
        },
        {
            "title": "010265670004-107-09-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026567&Seq=016&Type=8"
        },
        {
            "title": "010265670003-107-09-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026567&Seq=015&Type=8"
        },
        {
            "title": "010265670002-107-09-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026567&Seq=014&Type=8"
        }
    ]
}